I am more than happy to address that because I have to say we have engaged with three other undertakings, companies, entities similar to GILC, and they just have not compared. We find that your platform, the way that you conduct the meetings and introduce us to people all around the world, and I particularly have appreciated the follow-up and the support that your team has provided.

I haven’t seen that from other companies. It seems that you pay a fee and then you might get a chance to pitch and they forget about you and that’s it, whereas GILC to the point of today is constantly seeking to help us get more exposure and introduce people, and we’ve actually already had investment from some GILC investors.

So we look forward to continuing to work with your team and want to thank you. Bottom line, it just wasn’t a one-time fee and then we’re done. We found it to instead have been GILC serving as a really true partner with us.

About AccuFix Surgical

AccuFix was founded by a team of veteran healthcare executives with over 300 years of combined industry experience. The company holds six active patents and two trademarks, focusing on minimally invasive solutions that prioritize "bone-sparing" techniques for long-term patient health.

Discover the future of orthopedic surgery with AccuFix Surgical. In this exclusive interview with the Global Investment Leaders Club, the team shares their FDA-cleared solution for Hallux Rigidus, designed to preserve natural joint anatomy and restore active lifestyles.

With 300+ successful implants, AccuFix’s patented AccuJoint removes just 1 mm of bone, offering improved mobility and pain reduction compared to traditional treatments.

Highlights:

 • Breakthrough bone-sparing technology
 • Strong clinical outcomes within 12 months
 • $9B market opportunity & growth strategy
 • $4.3M raised and ongoing expansion

Speakers:

John K. Evans (CEO), Dr. Aaron Shemenski (CMO), Jamie Lineberger (Co-Chairman)